SiliconANGLEValley
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science…
Read at SiliconANGLE ↗Related
ValleyRobotics startup Enact Intelligence nabs $30M funding round SiliconANGLE
ValleyNirva raises $25M to make AI jewelry with ‘perspective’ that listens and provides insights SiliconANGLE

ValleyOpenAI working on new $30B raise at $1.25T valuation ahead of IPO TechCrunch AI

OpenAI, Google partnership targets enterprise model choice AI Business

ValleyNirva raises $33M for a pendant that only listens to you TechCrunch AI
